|
US4099012A
(en)
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
|
US4481142A
(en)
|
1979-02-07 |
1984-11-06 |
Hoffmann-La Roche Inc. |
Pyrimido-2-benzazepines
|
|
NZ192803A
(en)
|
1979-02-07 |
1984-08-24 |
Hoffmann La Roche |
Pyrimido-2-benzazepines and pharmaceutical compositions
|
|
US4469633A
(en)
|
1980-05-16 |
1984-09-04 |
Hoffmann-La Roche Inc. |
N-oxides of 5-oxo-1-phenyl-2-benzazepines
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0273697A3
(en)
|
1986-12-30 |
1989-11-29 |
Merck & Co. Inc. |
2-benzazepines with 5- and 6- membered heterocyclic rings
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5166151A
(en)
|
1988-03-25 |
1992-11-24 |
Merck & Co., Inc. |
2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
|
|
US5210082A
(en)
|
1991-05-16 |
1993-05-11 |
Merck & Co., Inc. |
2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
US5747487A
(en)
*
|
1993-07-29 |
1998-05-05 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
|
US5595721A
(en)
|
1993-09-16 |
1997-01-21 |
Coulter Pharmaceutical, Inc. |
Radioimmunotherapy of lymphoma using anti-CD20
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
TW486480B
(en)
|
1996-03-08 |
2002-05-11 |
Zeneca Ltd |
Azolobenzazepine derivatives and compositions and method of use thereof
|
|
WO1998028281A1
(en)
|
1996-12-23 |
1998-07-02 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
|
GB9713087D0
(en)
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
RU2198885C2
(ru)
|
1997-09-29 |
2003-02-20 |
Мейдзи Сейка Кайся Лтд. |
Производные трициклического триазолобензазепина, способы их получения, фармацевтическая композиция и способ лечения аллергических заболеваний, промежуточные соединения и способы их получения
|
|
US6277844B1
(en)
|
1998-09-14 |
2001-08-21 |
Sydney Spector |
Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
|
|
WO2000067754A1
(en)
|
1999-05-12 |
2000-11-16 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
|
CN101259270A
(zh)
*
|
1999-08-11 |
2008-09-10 |
拜奥根Idec公司 |
用抗cd20抗体治疗累及骨髓的非霍奇金淋巴瘤患者
|
|
WO2001034194A1
(en)
*
|
1999-11-08 |
2001-05-17 |
Idec Pharmaceuticals Corporation |
Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy
|
|
US6480162B2
(en)
*
|
2000-01-12 |
2002-11-12 |
Emag Technologies, Llc |
Low cost compact omini-directional printed antenna
|
|
EP1286692A4
(en)
*
|
2000-04-25 |
2004-11-17 |
Idec Pharma Corp |
INTRATHECAL ADMINISTRATION OF RITUXIMAB FOR THE TREATMENT OF LYMPHOMAS OF THE CENTRAL NERVOUS SYSTEM
|
|
HUP0400639A3
(en)
|
2000-12-21 |
2010-03-29 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors and pharmaceutical compositions containing them
|
|
US6686352B2
(en)
|
2001-05-18 |
2004-02-03 |
Hoffmann-La Roche Inc. |
Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
|
|
WO2003013545A1
(en)
|
2001-08-09 |
2003-02-20 |
Actelion Pharmaceuticals Ltd |
Novel benzo-fused heterocycles as endothelin antagonisits
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
|
PT1847539E
(pt)
|
2002-12-24 |
2009-10-06 |
Astrazeneca Ab |
Derivados de quinazolina
|
|
JP2006517949A
(ja)
|
2003-02-17 |
2006-08-03 |
ファルマシア・イタリア・ソシエタ・ペル・アツィオーニ |
キナーゼ阻害剤としての四環系ピラゾール誘導体、前記誘導体の製造方法、および前記誘導体を含む医薬組成物
|
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
|
US7141568B2
(en)
|
2003-07-09 |
2006-11-28 |
Pfizer Italia S.R.L. |
Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
US20050025605A1
(en)
*
|
2003-07-30 |
2005-02-03 |
Vrana John J. |
Locator stud and method of assembly
|
|
JP4741491B2
(ja)
|
2003-08-07 |
2011-08-03 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
抗増殖剤としての２，４−ピリミジンジアミン化合物および使用
|
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
|
RS50568B8
(sr)
*
|
2004-05-14 |
2019-08-30 |
Millennium Pharm Inc |
Jedinjenja i postupci za inhibiciju mitotičke progresije inhibiranjem aurora kinaze
|
|
JP4812763B2
(ja)
|
2004-05-18 |
2011-11-09 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途
|
|
WO2006003440A1
(en)
|
2004-07-05 |
2006-01-12 |
Astex Therapeutics Limited |
3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors
|
|
DE602005024274D1
(de)
|
2004-07-16 |
2010-12-02 |
Sunesis Pharmaceuticals Inc |
Als aurora-kinase-inhibitoren nutzbare thienopyrimidine
|
|
ATE421996T1
(de)
|
2004-11-15 |
2009-02-15 |
Rigel Pharmaceuticals Inc |
Verfahren zur herstellung optisch aktiver n- carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase
|
|
GB2420559B
(en)
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
|
JP2008520713A
(ja)
|
2004-11-17 |
2008-06-19 |
ミイカナ セラピューティクス インコーポレイテッド |
キナーゼ阻害剤
|
|
WO2006070202A1
(en)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Pyrazole derivatives having kinase modulating activity
|
|
EP2395000A1
(en)
|
2004-12-30 |
2011-12-14 |
Astex Therapeutics Limited |
Benzimidazole compounds that modulate the activity of CDK, GSK and aurora kinases
|
|
EP1836199A1
(en)
|
2004-12-30 |
2007-09-26 |
Astex Therapeutics Limited |
Thiazole and isothiazole derivatives that modulate the activity of cdk, gsk and aurora kinases
|
|
JP2008526723A
(ja)
|
2004-12-30 |
2008-07-24 |
アステックス、セラピューティックス、リミテッド |
Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するピラゾール誘導体
|
|
US7485661B2
(en)
|
2005-01-18 |
2009-02-03 |
Pfizer Italia S.R.L. |
Heterobicyclic pyrazole derivatives as kinase inhibitors
|
|
US20070104785A1
(en)
*
|
2005-07-29 |
2007-05-10 |
Navale Suryakant V |
Tablets of linezolid form iii and processes for their preparation
|
|
CA2622352C
(en)
|
2005-09-30 |
2014-05-27 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
|
TW200734327A
(en)
|
2005-11-03 |
2007-09-16 |
Vertex Pharma |
Aminopyrimidines useful as kinase inhibitors
|
|
MX2008008320A
(es)
*
|
2005-12-23 |
2008-09-03 |
Smithkline Beecham Corp |
Inhibidores de azaindol de aurora cinasas.
|
|
CN100346830C
(zh)
*
|
2005-12-28 |
2007-11-07 |
上海交通大学医学院附属瑞金医院 |
一种治疗b细胞淋巴瘤的药物组合物
|
|
US7820821B2
(en)
*
|
2006-02-10 |
2010-10-26 |
Transtech Pharma, Inc. |
Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
|
|
TW200808311A
(en)
|
2006-03-30 |
2008-02-16 |
Nerviano Medical Sciences Srl |
Use of a kinase inhibitor for the treatment of particular resistant tumors
|
|
WO2007132221A1
(en)
|
2006-05-12 |
2007-11-22 |
Cyclacel Limited |
Combined anticancer pyrimidine-thiazole aurora kinase inhibitors
|
|
GB0609530D0
(en)
|
2006-05-12 |
2006-06-21 |
Cyclacel Ltd |
Combination
|
|
WO2007132220A1
(en)
|
2006-05-12 |
2007-11-22 |
Cyclacel Limited |
Combination of a 2-substituted-4-heter0aryl-pyrimidine amine with a cytotoxic drug and use thereof in the treatment of a proliferative disorder
|
|
EP2037919A2
(en)
*
|
2006-06-30 |
2009-03-25 |
Schering Corporation |
Method of using substituted piperidines that increase p53 activity
|
|
US7718648B2
(en)
|
2006-08-09 |
2010-05-18 |
Millennium Pharmaceuticals, Inc. |
Pyridobenzazepine compounds and methods for inhibiting mitotic progression
|
|
CL2007003244A1
(es)
*
|
2006-11-16 |
2008-04-04 |
Millennium Pharm Inc |
Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
|
|
US20090023743A1
(en)
*
|
2007-05-09 |
2009-01-22 |
Abbott Laboratories |
Inhibitors of protein kinases
|
|
US20090203671A1
(en)
|
2007-11-27 |
2009-08-13 |
Abbott Laboratories |
Method of treating cancer
|
|
US20110033461A1
(en)
*
|
2008-03-12 |
2011-02-10 |
Vladimir Ratushny |
Combination Therapy for the Treatment of Cancer
|
|
MX2011006725A
(es)
|
2008-12-22 |
2011-09-15 |
Millennium Pharm Inc |
Combinacion de inhibidores de aurora cinasa y anticuerpos anti-cd20.
|
|
JO3635B1
(ar)
*
|
2009-05-18 |
2020-08-27 |
Millennium Pharm Inc |
مركبات صيدلانية صلبة وطرق لانتاجها
|
|
JO3434B1
(ar)
*
|
2009-07-31 |
2019-10-20 |
Millennium Pharm Inc |
مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري
|
|
EP2496604B1
(en)
*
|
2009-11-06 |
2017-08-23 |
IDEXX Laboratories, Inc. |
Canine anti-cd20 antibodies
|
|
CN102770024A
(zh)
*
|
2010-02-19 |
2012-11-07 |
米伦纽姆医药公司 |
4-{[9-氯-7-(2-氟-6-甲氧基苯基)-5h-嘧啶并[5,4-d][2]苯并氮杂卓-2基]氨基}-2-甲氧基苯甲酸钠的结晶形式
|